Search results for "Neuropsychological Tests"

showing 10 items of 523 documents

Reviewing the impact of problem structure on planning: a software tool for analyzing tower tasks.

2010

Cognitive, clinical, and neuroimaging studies on planning abilities most frequently implement the Tower of London task or one of its variants. Yet, cumulating evidence from a series of experiments suggests that the commonly used approximation of problem difficulty in terms of the minimum number of moves for goal attainment is too coarse a measure for the underlying cognitive operations, and in some cases may be even misleading. Rather, problem difficulty can be more specifically characterized by a set of structural task parameters such as the number and nature of optimal and suboptimal solution paths, the required search depths, the patterns of intermediate and goal moves, goal hierarchies …

Structure (mathematical logic)business.industrymedia_common.quotation_subjectCognitionAmbiguityNeuropsychological TestsTower (mathematics)Task (project management)Behavioral NeuroscienceSoftwareCognitionHuman–computer interactionHumansProblem setSet (psychology)PsychologybusinessGoalsProblem SolvingSoftwaremedia_commonBehavioural brain research
researchProduct

Association of basal forebrain volumes and cognition in normal aging.

2013

The basal forebrain cholinergic system (BFCS) is known to undergo moderate neurodegenerative alterations during normal aging and severe atrophy in Alzheimer's disease (AD). It has been suggested that functional and structural alterations of the BFCS mediate cognitive performance in normal aging and AD. But, it is still unclear to what extend age-associated cognitive decline can be related to BFCS in normal aging. We analyzed the relationship between BFCS volume and cognition using MRI and a comprehensive neuropsychological test battery in a cohort of 43 healthy elderly subjects spanning the age range from 60 to 85 years. Most notably, we found significant associations between general intell…

TelencephalonMaleAgingCognitive NeuroscienceIntelligenceExperimental and Cognitive PsychologyNeuropsychological TestsNucleus basalisWhite matterCohort StudiesBehavioral NeuroscienceExecutive FunctionAtrophyCognitionMemorymedicineHumansAttentionEffects of sleep deprivation on cognitive performanceddc:610Cognitive declineAgedAged 80 and overIntelligence TestsBasal forebrainmedicine.diagnostic_testCognitionNeuropsychological testOrgan SizeMiddle Agedmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureLinear ModelsEducational StatusFemaleanatomy & histology [Telencephalon]PsychologyNeuroscience
researchProduct

Modulation of higher-order olfaction components on executive functions in humans

2015

The prefrontal (PFC) and orbitofrontal cortex (OFC) appear to be associated with both executive functions and olfaction. However, there is little data relating olfactory processing and executive functions in humans. The present study aimed at exploring the role of olfaction on executive functioning, making a distinction between primary and more cognitive aspects of olfaction. Three executive tasks of similar difficulty were used. One was used to assess hot executive functions (Iowa Gambling Task-IGT), and two as a measure of cold executive functioning (Stroop Colour and Word Test-SCWT and Wisconsin Card Sorting Test-WCST). Sixty two healthy participants were included: 31 with normosmia and …

Test de StroopOlfactelcsh:Medicine:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Thinking::Decision Making [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Psychophysiology::Sensation::Smell [Medical Subject Headings]AudiologyPrefrontal cortex:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Executive FunctionOlfaction Disorderspiriform cortexHyposmiaOlfactory threshold:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests::Stroop Test [Medical Subject Headings]older-adultsalzheimers-diseaselcsh:SciencePsychiatryMultidisciplinaryCognitive flexibilityCognitionMiddle AgedExecutive functionsSmellCognitive inhibitionNeurology:Diseases::Nervous System Diseases::Neurologic Manifestations::Sensation Disorders::Olfaction Disorders [Medical Subject Headings]FemaleFrontal lobemedicine.symptomPsychologyperformanceResearch ArticleAdultmedicine.medical_specialtyAdolescentOlfactionventromedial prefrontal cortexYoung AdultNeurologiamild cognitive impairmentLòbul frontalPruebas neuropsicológicasmedicineHumansTrastornos del olfatoPsiquiatriaToma de decisionesCognición:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Cognition [Medical Subject Headings]lcsh:Rdecision-makingOlfactory Perceptionodor identificationdeficits:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Executive Function [Medical Subject Headings]lcsh:QOlfatoStroop effectdiscrimination
researchProduct

Naming People Ignoring Semantics in a Patient with Left Frontal Damage

1999

Studies about proper name anomia generally assume that persons' names are harder to recall than other semantic information one knows about them and that name retrieval is not possible without biographical knowledge. We describe a patient, SB, who, after a left frontal haemorrhage, was unable to recall any biographical information about people she could name. Moreover, she had a normal score in an Object Picture Naming Test, but gave confabulatory answers in a Semantic Questionnaire involving the same items. The role of frontal function in producing this pattern of impairment is discussed, together with the possible existence of a direct route from visual perception to proper name retrieval.

Visual perceptionCognitive NeuroscienceExperimental and Cognitive PsychologyNeuropsychological TestsSemanticsSurveys and QuestionnairesHumansProper nounAgedAged 80 and overDysexecutive syndromeRecallObject (philosophy)Frontal LobeSemanticsTest (assessment)StrokeProsopagnosiaNeuropsychology and Physiological PsychologyFrontal lobeFaceFemaleAmnesiaCuesTomography X-Ray ComputedPsychologyIntracranial HemorrhagesCognitive psychologyCortex
researchProduct

Association between osteocalcin and cognitive performance in healthy older adults.

2016

INTRODUCTION: cognitive deterioration and reductions of bone health coincide with increasing age. We examine the relationship between bone composition and plasma markers of bone remodelling with measures of cognitive performance in healthy adults.METHODS: this cross-sectional study included 225 old (52% women, mean age: 74.4 ± 3.3 years) and 134 young (52% women, mean age: 23.4 ± 2.7 years) adult participants from the MyoAge project. Whole body bone mineral density was measured by dual-energy X-ray absorptiometry. Blood analyses included a panel of bone-related peptides (dickkopf-1, osteoprotegerin, osteocalcin (OC), osteopontin, sclerostin, parathyroid hormone and fibroblast growth factor …

cognitionMaleAgingosteopontinvery elderlyCognitive declinesclerostinNeuropsychological Testsolder peopleExecutive FunctionAbsorptiometry PhotonBone Densityblood analysiscognitive defectphoton absorptiometry80 and overcalcium blood leveldickkopf 1 protein25 hydroxyvitamin D; calcium; dickkopf 1 protein; fibroblast growth factor 23; osteocalcin; osteopontin; osteoprotegerin; parathyroid hormone; sclerostin; biological marker; osteocalcin adult; aged; Article; blood analysis; bone density; bone remodeling; calcium blood level; cognition; controlled study; cross-sectional study; dual energy X ray absorptiometry; episodic memory; executive function; female; human; male; neuropsychological test; priority journal; working memory; adolescent; age; aging; blood; clinical trial; cognitive aging; cognitive defect; comparative study; Europe; metabolic bone disease; multicenter study; photon absorptiometry; psychology; sex difference; short term memory; very elderly; young adult Absorptiometry Photon; Adolescent; Adult; Age Factors; Aged; Aged 80 and over; Aging; Biomarkers; Bone Density; Bone Diseases Metabolic; Bone Remodeling; Cognition; Cognition Disorders; Cognitive Aging; Cross-Sectional Studies; Europe; Executive Function; Female; Humans; Male; Memory Episodic; Memory Short-Term; Neuropsychological Tests; Osteocalcin; Sex Factors; Young Adult; Ageing; Cognitive decline; Older people; Osteocalcincomparative studyAged 80 and overdual energy X ray absorptiometryadultAge Factorsclinical trialepisodic memorybiological markerPhotonEuropeagedMemory Short-Termfemalepriority journalyoung adultmetabolic bone diseaseBone RemodelingBone DiseasesEpisodicResearch PaperAdolescentMemory Episodicsex differenceOsteocalcinosteocalcinpsychologyArticleworking memoryfibroblast growth factor 23short term memorySex FactorsbloodMemoryparathyroid hormonecross-sectional studyHumanscontrolled studyhumanAbsorptiometrycalciumcognitive agingcognitive declineBone Diseases MetabolicAgeingikääntyminen25 hydroxyvitamin Dmulticenter studyCross-Sectional StudiesageShort-Termosteoprotegerinneuropsychological testMetabolicOlder peopleCognition DisordersBiomarkers
researchProduct

The combined effect of lower extremity function and cognitive performance on perceived walking ability among older people : a 2-year follow-up study

2018

Background We studied the combined effects of cognitive performance and lower extremity function on self-reported walking modifications and walking difficulty and on self-reported walking difficulty incidence over a 2-year follow-up. Methods A total of 848 community-dwelling older people aged 75-90 years participated at baseline, 816 at the 1-year follow-up, and 761 at the 2-year follow-up. Baseline lower extremity function was measured with the Short Physical Performance Battery (<10 vs. ≥10) and cognitive performance with the Mini-Mental State Examination (<24 vs. ≥24). Difficulty in walking 2 km was self-reported and categorized into no difficulties, no difficulties but walking modificat…

kognitioMalecognitionAgingvanhuksetWalkingNeuropsychological TestsCohort Studies0302 clinical medicine030212 general & internal medicineta315FinlandAged 80 and overmedicine.diagnostic_testDepressionHazard ratioAge FactorsCognitionta3141Physical Functional Performancefyysinen kuntoDifficulty walkingLower ExtremityEducational StatusFemaleCohort studykognitiiviset taidotmedicine.medical_specialtyVision Disordersfyysinen toimintakykyOdds03 medical and health sciencesmobility limitationPhysical medicine and rehabilitationSex Factorsphysical functionmedicineliikuntakykyHumansEffects of sleep deprivation on cognitive performanceMini–Mental State Examinationbusiness.industryphysical performanceConfidence intervalChronic DiseaseExercise TestSelf ReportGeriatrics and Gerontologybusinesshuman activities030217 neurology & neurosurgeryFollow-Up StudiesJournals of Gerontology. Series A: Biological Sciences and Medical Sciences
researchProduct

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Human.

2013

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognit…

lcsh:MedicineNeuropsychological TestsSocial and Behavioral SciencesPrefrontal cortexReceptores de cannabinoides:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Executive FunctionEndocrinologyCognitionWisconsin Card Sorting TestEndocrinologiaHuman PerformanceMedicinePsychologyendocannabinoid systemPrefrontal cortexlcsh:ScienceProblem SolvingPsychiatryMultidisciplinaryCognitive NeurologyCognitive flexibilityPresa de decisionsCognitionMiddle AgedExecutive functionsexecutive functionsHumanos2-arachidonoylglycerolSubstance abuseEndocannabinoidesMental HealthNeurologyCognicióMedicineFemalelipids (amino acids peptides and proteins):Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors G-Protein-Coupled::Receptors Cannabinoid [Medical Subject Headings]Animal behaviorClinical psychology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Arachidonic Acids [Medical Subject Headings]HumanResearch ArticleAdultN-arachidonoylethanolamine:Psychiatry and Psychology::Mental Disorders::Substance-Related Disorders::Marijuana Abuse [Medical Subject Headings]Polyunsaturated AlkamidesCognitive NeuroscienceDecision MakingArachidonic AcidsGlyceridesYoung AdultCannabinoides -- ReceptorsNeuropsychologyCànnabis:Diseases::Nervous System Diseases::Neurodegenerative Diseases [Medical Subject Headings]Pruebas neuropsicológicasÁcidos araquidónicosHumansFunción ejecutivaBiologyCannabisCannabinoides -- Efectes fisiològics:Anatomy::Nervous System::Central Nervous System [Medical Subject Headings]Behavior:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoids [Medical Subject Headings]business.industrylcsh:RCognitive Psychologymedicine.diseaseIowa gambling taskEnfermedades neurodegenerativasAbuso de marihuanaSistema nervioso central:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Executive Function [Medical Subject Headings]lcsh:QbusinessDecision makingStroop effectNeuroscienceEndocannabinoids
researchProduct

In utero exposure to mixtures of xenoestrogens and child neuropsychological development.

2014

BACKGROUND: To date, no epidemiological studies have explored the impact and persistence of in utero exposure to mixtures of xenoestrogens on the developing brain. We aimed to assess whether the cumulative effect of xenoestrogens in the placenta is associated with altered infant neuropsychological functioning at two and at four years of age, and if associations differ among boys and girls. METHODS: Cumulative prenatal exposure to xenoestrogens was quantified in the placenta using the biomarker Total Effective Xenoestrogen Burden (TEXB-alpha) in 489 participants from the INMA (Childhood and the Environment) Project. TEXB-alpha was split in tertiles to test its association with the mental and…

medicine.medical_specialty010501 environmental sciencesNeuropsychological Tests01 natural sciencesBiochemistryBayley Scales of Infant DevelopmentXenobioticsToxicology03 medical and health scienceschemistry.chemical_compoundPregnancyEpidemiologyMedicineHumansXenobiòtics -- ToxicologiaTests neuropsicològicsMotor skill030304 developmental biology0105 earth and related environmental sciencesGeneral Environmental SciencePsychomotor learning0303 health sciencesbusiness.industryConfoundingNeuropsychologyCognitionEstrogens3. Good healthXenoestrogenchemistryChild PreschoolPrenatal Exposure Delayed EffectsFemalebusinessEmbaràs--ComplicacionsClinical psychologyEstrògens -- ToxicologiaEnvironmental research
researchProduct

Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 …

2020

Background: Alkaline phosphatase has been found on neuronal membranes and plasma alkaline phosphatase (ALP) activity increases during brain injury and cerebrovascular diseases, suggesting that its levels may reflect the neuronal loss. It is known that ALP is higher in subjects affected by Alzheimer’s dementia and inversely correlated with cognitive functions. No study has investigated the relationship between ALP and cognitive functions in old-age subject with pre-clinical cognitive impairment. Methods: This is a cross-sectional study with data gathered from the ReGAl 2.0 project (Rete Geriatrica Alzheimer-Geriatric Network on Alzheimer’s disease), a large Italian multicentric clinical-base…

medicine.medical_specialtyAgingGeriatric medicineAging Biochemistry Cognition Dementia Geriatric medicine Aged Alkaline Phosphatase Cognition Cross-Sectional Studies Humans Italy Neuropsychological Tests Alzheimer Disease Cognitive DysfunctionPopulationNeuropsychological TestsBiochemistry03 medical and health sciences0302 clinical medicineCognitionAlzheimer DiseaseInternal medicinemedicineMemory spanDementiaHumansCognitive Dysfunction030212 general & internal medicineCognitive declineeducationAgededucation.field_of_studybusiness.industryNeuropsychologyCognitionmedicine.diseaseAlkaline PhosphataseEndocrinologyCross-Sectional StudiesItalyCohortAlkaline phosphataseSettore MED/26 - NeurologiaDementiaGeriatrics and Gerontologybusiness030217 neurology & neurosurgery
researchProduct

Mild cognitive impairment: A systematic review

2007

MCI is a nosological entity proposed as an intermediate state between normal aging and dementia. The syndrome can be divided into two broad subtypes: amnestic MCI ( aMCI) characterized by reduced memory, and non- amnestic MCI ( naMCI) in which other cognitive functions rather than memory are mostly impaired. aMCI seems to represent an early stage of AD, while the outcomes of the naMCI subtypes appear more heterogeneous - including vascular dementia, frontotemporal dementia or dementia with Lewy bodies- but this aspect is still under debate. MCI in fact represents a condition with multiple sources of heterogeneity, including clinical presentation, etiology, and prognosis. To improve classifi…

medicine.medical_specialtyApolipoprotein E4Neuropsychological TestsSeverity of Illness Indexbehavioral disciplines and activitiesPhysical medicine and rehabilitationNeuroimagingAlzheimer DiseaseFluorodeoxyglucose F18Risk Factorsmental disordersEpidemiologySeverity of illnessmedicineHumansDementiaVascular dementiaapolipoprotein EAlzheimer disease; apolipoprotein E; biomarkers; diagnosis; mild congnitive impairmentMemory Disordersbusiness.industryDementia VascularGeneral NeuroscienceBrainCognitionGeneral Medicinemedicine.diseaseMagnetic Resonance Imagingmild congnitive impairmentdiagnosiPsychiatry and Mental healthClinical PsychologyEtiologybiomarkerSettore MED/26 - NeurologiaRadiopharmaceuticalsGeriatrics and GerontologyCognition DisordersbusinessFrontotemporal dementia
researchProduct